Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
87.5M
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
29.7M
-
Shares change
-
+6.2M
-
Total reported value, excl. options
-
$538M
-
Value change
-
+$109M
-
Put/Call ratio
-
11.47
-
Number of buys
-
63
-
Number of sells
-
-41
-
Price
-
$18.20
Significant Holders of Kura Oncology, Inc. - Common Stock (KURA) as of Q2 2018
122 filings reported holding KURA - Kura Oncology, Inc. - Common Stock as of Q2 2018.
Kura Oncology, Inc. - Common Stock (KURA) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.7M shares
of 87.5M outstanding shares and own 33.96% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (3.9M shares), FMR LLC (3.37M shares), GREAT POINT PARTNERS LLC (2.63M shares), BVF INC/IL (2.06M shares), BlackRock Inc. (2M shares), VICTORY CAPITAL MANAGEMENT INC (1.49M shares), VANGUARD GROUP INC (1.43M shares), EAGLE ASSET MANAGEMENT INC (1.37M shares), Partner Fund Management, L.P. (1.09M shares), and STATE STREET CORP (1.04M shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.